Session Details

[3MS-18]【J】Aiming to understand the diversity of autism spectrum disorder -From animals to humans, from molecules to individuals, at the forefront of cross-disciplinary research-

Fri. Dec 5, 2025 11:15 AM - 12:35 PM JST
Fri. Dec 5, 2025 2:15 AM - 3:35 AM UTC
Room 18(Pacifico Yokohama Conference Center 5F, 511+512)
Organizer: Shigeo Uchino (Teikyo University), Hiroko Kotajima (Tokyo Metropolitan Institute of Medical Science)
ASD is a congenital developmental disorder that exhibits various symptoms, including impaired social communication, restricted interests and behavior, and sensory disturbance. We will present topics at the forefront of cross-disciplinary ASD research, such as model mice based on clinical findings, cross-species pathophysiology verification using model mice and iPS cells, and approaches from other diseases such as tuberous sclerosis.

[3MS-18-01]Behavioral diversity exhibited by Shank3 deficient mice

○Shigeo Uchino1 (1. Teikyo Univ)
Comment()

[3MS-18-02]Understanding autism spectrum disorders through patient-derived iPS cells and disease model mice

○Takanobu Nakazawa1 (1. Tokyo University of Agriculture)
Comment()

[3MS-18-03]Sensory and Cognitive Features of Autism Spectrum Disorder Revealed with Human Participants and Mouse Models

○Makoto Wada1 (1. Research Institute of National Rehabilitation Center for Persons with Disabilities)
Comment()

[3MS-18-04]Impact of brain Dp427 and Dp140 deficiency on social behavior in animal models of Duchenne muscular dystrophy

○Eri Takeuchi1,2, Yoshitsugu Aoki2 (1. Department of Memory Neuroscience, Tokyo Metropolitan Institute for Geriatrics and Gerontology, 2. Department of Molecular Therapy, National Center of Neurology and Psychiatry (NCNP))
Comment()

[3MS-18-05]Effects of Genotypic Interaction Under Pair-Housing on Social Behavior and DNA Methylation Profiles in a Tuberous Sclerosis Mouse Model

○Hiroko Kotajima1, Atsushi Sato2, Shinya Kasai3, Yoko Hagino1, Miho Tanaka4, Yukio Takamatsu, Yasumasa Nishito5, Shigeo Uchino6, Kazutaka Ikeda1,7 (1. Addictive Substance Project, Department of Clinical Medical Sciences, Tokyo Metropolitan Institute of Medical Science, 2. Tums Wanpaku Clinic, 3. Faculty of Life and Environmental Sciences, Department of Biotechnology, University of Yamanashi, 4. Faculty of Education, Tokyo Gakugei University, 5. Center for Basic Technology Research, Tokyo Metropolitan Institute of Medical Science, 6. Department of Biosciences, Faculty of Science and Engineering, Teikyo University, 7. Department of Neuropsychopharmacology, National Institute of Mental Health, National Center of Neurology and Psychiatry)
Comment()